Soha El Sheikh
Overview
Explore the profile of Soha El Sheikh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El Sheikh S, Mansour M, Provenzano E, Shaaban A, Lee A, Mir Y, et al.
Histopathology
. 2024 Dec;
PMID: 39704183
Aims: Atypical ductal hyperplasia and flat epithelial atypia (FEA) have defined diagnostic criteria, yet there is variation in the interpretation of these criteria, particularly when the atypia is present in...
2.
Mansour H, Tran-Dang M, Walkden M, Boleti E, Barod R, Patki P, et al.
Nat Rev Urol
. 2024 Jun;
22(1):8-25.
PMID: 38907039
Advancements in imaging modalities have increased the frequency of renal mass discovery. Imaging has typically been considered sufficient to guide management for a large proportion of these tumours, but renal...
3.
Banerjee S, Acedo P, El Sheikh S, Harati R, Meecham A, Williams N, et al.
Front Immunol
. 2023 Nov;
14:1188087.
PMID: 38022682
Introduction: Triple negative breast cancer (TNBC) is a subtype of breast cancer characterised by its high tumourigenic, invasive, and immunosuppressive nature. Photodynamic therapy (PDT) is a focal therapy that uses...
4.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Int Urol Nephrol
. 2023 Nov;
56(4):1323-1333.
PMID: 37980689
Purpose: A re-transurethral resection of the bladder (re-TURB) is a well-established approach in managing non-muscle invasive bladder cancer (NMIBC) for various reasons: repeat-TURB is recommended for a macroscopically incomplete initial...
5.
Sylvester R, Rodriguez O, Hernandez V, Turturica D, Bauerova L, Bruins H, et al.
Eur Urol
. 2023 Feb;
83(5):e140-e141.
PMID: 36841687
No abstract available.
6.
Dawood A, MacMahon S, Dang M, Tran M, Bex A, Boleti E, et al.
Front Oncol
. 2023 Feb;
13:1111706.
PMID: 36816927
Renal cell carcinoma still carries a poor prognosis despite therapeutic advancements. Detection of genetic mutations is vital in improving our understanding of this disease as well as potential role in...
7.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Eur Urol Oncol
. 2023 Jan;
6(2):214-221.
PMID: 36670042
Background: Ta grade 3 (G3) non-muscle-invasive bladder cancer (NMIBC) is a relatively rare diagnosis with an ambiguous character owing to the presence of an aggressive G3 component together with the...
8.
Neves J, Roberts K, Nguyen J, El Sheikh S, Tran-Dang M, Horsfield C, et al.
iScience
. 2022 Nov;
25(11):105389.
PMID: 36345344
Succinate dehydrogenase (SDH)-deficient renal cell carcinoma represents a rare subtype of hereditary kidney cancer. Clinical diagnosis can be challenging and there is little evidence to guide systemic therapeutic options. We...
9.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Eur Urol Focus
. 2022 May;
8(6):1627-1634.
PMID: 35577750
Background: The pathological existence and clinical consequence of stage T1 grade 1 (T1G1) bladder cancer are the subject of debate. Even though the diagnosis of T1G1 is controversial, several reports...
10.
El Sheikh S, Rathbone M, Chaudhary K, Joshi A, Lee J, Muthukumar S, et al.
Clin Breast Cancer
. 2022 Mar;
22(4):381-390.
PMID: 35260351
Introduction: Our breast screening unit was identified as high outlier for B3 lesions with a low positive predictive value (PPV) compared to the England average. This prompted a detailed internal...